Choi JN - Search Results

1

Successful Treatment of In-Transit Metastatic Melanoma in a Renal Transplant Patient With Combination T-VEC/Imiquimod Immunotherapy.

Sunshine JC, Sosman J, Shetty A, Choi JN. Sunshine JC, et al. Among authors: choi jn. J Immunother. 2020 May;43(4):149-152. doi: 10.1097/CJI.0000000000000319. J Immunother. 2020. PMID: 32235165

2

Treatment of in-transit melanoma with intralesional bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: a report of 3 cases.

Kibbi N, Ariyan S, Faries M, Choi JN. Kibbi N, et al. Among authors: choi jn. J Immunother. 2015 Nov-Dec;38(9):371-5. doi: 10.1097/CJI.0000000000000098. J Immunother. 2015. PMID: 26448581 Free PMC article.

3

Advancements in unresectable melanoma: a multidisciplinary perspective.

Malecek MK, Robinson JK, Bilimoria K, Choi JN, Choi J, Gerami P, Kruser T, Kuzel T, Martini M, Strauss JB, Wayne J, Sosman J, Chandra S. Malecek MK, et al. Among authors: choi j, choi jn. Melanoma Manag. 2016 Sep;3(3):171-175. doi: 10.2217/mmt-2016-0003. Epub 2016 Aug 16. Melanoma Manag. 2016. PMID: 30190886 Free PMC article. No abstract available.

4

Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature.

Kosche C, Stout M, Sosman J, Lukas RV, Choi JN. Kosche C, et al. Among authors: choi jn. Melanoma Res. 2020 Jun;30(3):313-316. doi: 10.1097/CMR.0000000000000642. Melanoma Res. 2020. PMID: 31567590 Review.

5

Periocular Melanoma In Situ Treated With Imiquimod.

Elia MD, Lally SE, Hanlon AM, Choi JN, Servat JJ, Shields JA, Shields CL, Levin F. Elia MD, et al. Among authors: choi jn. Ophthalmic Plast Reconstr Surg. 2016 Sep-Oct;32(5):371-3. doi: 10.1097/IOP.0000000000000554. Ophthalmic Plast Reconstr Surg. 2016. PMID: 26325381

6

Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab.

Kosche C, Owen JL, Choi JN. Kosche C, et al. Among authors: choi jn. Dermatol Online J. 2019 Oct 15;25(10):13030/qt4md713j8. Dermatol Online J. 2019. PMID: 31735010 Free article.

7

Utilization of immunotherapy among patients with stage 4 melanoma: An analysis of the National Cancer Database from 2012 to 2016.

Shah PV, Choi JN, Fiessinger L, Nardone B, Nguyen CV, Liszewski W. Shah PV, et al. Among authors: choi jn. J Am Acad Dermatol. 2021 Mar;84(3):811-814. doi: 10.1016/j.jaad.2020.06.031. Epub 2020 Jun 14. J Am Acad Dermatol. 2021. PMID: 32553633 No abstract available.

8

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors.

Choi J, Anderson R, Blidner A, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Lacouture ME. Choi J, et al. Support Care Cancer. 2020 Dec;28(12):6119-6128. doi: 10.1007/s00520-020-05706-4. Epub 2020 Aug 27. Support Care Cancer. 2020. PMID: 32856211 Free PMC article. Review.

9

Cancer immunotherapy-related adverse events: causes and challenges.

Blidner AG, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Anderson R. Blidner AG, et al. Support Care Cancer. 2020 Dec;28(12):6111-6117. doi: 10.1007/s00520-020-05705-5. Epub 2020 Aug 28. Support Care Cancer. 2020. PMID: 32857220 Review.

10

Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.

Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM Jr, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M. Kibbi N, et al. Among authors: choi jn. JAMA Oncol. 2022 Apr 1;8(4):618-628. doi: 10.1001/jamaoncol.2021.7148. JAMA Oncol. 2022. PMID: 35050310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page